Adverse Events (> 1%) Leading to Discontinuation (Long-term Study)

Events

Total 11%

Diarrhea 4%

Abdominal pain 3%

Flatulence 3%

Headache 1%

2

Total patients, N = 567 (4-12 mg/d)

Previous slide

Next slide

Back to first slide

View graphic version